We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

HNVR:NASDAQHanover Bancorp, Inc. Analysis

Data as of 2026-06-13 - not real-time

$23.94

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

Hanover Bancorp is trading just below its 20‑day simple moving average, with the 20‑day SMA sitting above the 50‑day SMA, signalling a bullish trend continuation. The MACD histogram remains positive and the MACD line is above its signal line, reinforcing the bullish momentum. RSI hovers around the mid‑60s, indicating the stock is not yet overbought and still has room to climb. Volume has been stable, supporting the price action without signs of sudden pressure. The market price is modestly below the discounted cash‑flow fair value estimate, suggesting a small upside potential of roughly one percent. Fundamental metrics show a forward P/E near eight, well below the current trailing P/E and the industry average, highlighting an attractive valuation on a forward basis. Operating margins have expanded, and the recent quarterly report confirmed continued margin improvement and a cash dividend of $0.10 per share. The dividend yield of about 1.7% is backed by a payout ratio under 40%, indicating sustainability. The balance sheet is relatively clean with a low debt‑to‑equity profile and ample cash reserves. Overall, the combination of bullish technicals, modest undervaluation, and a sustainable dividend makes HNVR a compelling hold with limited short‑term upside.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish technical indicators (SMA crossover, MACD, RSI)
  • Limited upside to fair value
  • Sustainable dividend

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Undervalued relative to DCF and forward earnings
  • Margin expansion and earnings growth
  • Attractive dividend yield with low payout ratio

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Stable, low‑beta exposure to regional banking
  • Consistent dividend payments
  • Regulatory environment and modest growth outlook

Key Metrics & Analysis

Financial Health

Revenue Growth4.60%
Profit Margin12.30%
P/E Ratio22.8
ROE3.94%
ROA0.34%
P/B Ratio0.9
Op. Cash Flow$10.3M
Industry P/E16.8

Technical Analysis

TrendBullish
RSI59.8
Support$22.00
Resistance$24.55
MA 20$23.35
MA 50$22.94
MA 200$22.48
MACDBullish
VolumeStable
Fear & Greed Index89.86

Valuation

Fair Value$25.44
Target Price$24.25
Upside/Downside1.29%
GradeUndervalued
TypeValue
Dividend Yield1.67%

Risk Assessment

Beta0.61
Volatility21.89%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.